Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2024 – Interview with the Congress President
March 2024
EMJ sat down with EAHAD President, Wolfgang Miesbach, live at this year’s congress in Frankfurt, Germany. Miesbach highlighted key…
Read more
31st May 2022
Novel targets for therapy in TD β-Thalassaemia
The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…
25th May 2022
CME-Accredited Webinar on Biosimilars within Haematology & Oncology
This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.
13th May 2022
Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
28th April 2022
Clinical Challenges and Limitations in β-Thalassaemia Treatment and Their Impact on Patient Outcomes
Cappellini shares her expert insights into β-thalassaemia with our chair, internationally renowned surgeon Jonathan Sackier. With a focus…
30th September 2021
ESMO 2021 Jazz Pharmaceuticals AML symposium
Insight beyond Phase 3: Does real-world evidence impact how we treat high-risk AML…
3rd March 2021
Webinar: COVID-19 Challenges to Cancer and CAR-T Patients
This webinar has been funded by Novartis and focusses on the challenges posed by COVID-19 to cancer and CAR-T patients. Dr. Jonathan Sackier (UK) chairs…
2nd August 2018
NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI
Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in…
24th July 2018
EHA 2018 - Congress Highlights
Delve into the venue for this year’s European Hematology Association (EHA) Congress.
Loading posts...
« Previous
1
2
3
4
5
…
7
Next »